EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Covalent Activation of the C‐type Lectin DC‐SIGN

Jonathan Lefèbre iD, Maurice Besch iD, Noémi Csorba iD, Kristóf Garami iD, Zoltán Orgován iD, Gitta Schlosser iD, Iris Bermejo iD, Péter Ábrányi-Balogh iD, György M Keserű iD, Christoph Rademacher iD

Angewandte Chemie International Edition · 2026

DOI: 10.1002/anie.202520594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Jonathan Lefèbre und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna, 1090, Austria. Hauptthemen laut MEDLINE: Lectins, C-Type, Cell Adhesion Molecules, Receptors, Cell Surface. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Commission for a Marie-Skłodowska Curie Fellowship, Doctoral Excellence Fellowship Programme, Marie Skłodowska Curie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendritic cell‐specific intercellular adhesion molecule‐3‐grabbing non‐integrin (DC‐SIGN) is a C‐type lectin receptor expressed on antigen‐presenting cells, crucial for pathogen recognition and immune modulation. The shallow and polar carbohydrate binding site of DC‐SIGN presents challenges for ligand design. Here, we explored covalent modification targeting specific lysine residues as a novel strategy to modulate DC‐SIGN function. Screening a lysine‐targeted electrophilic fragment library using orthogonal functional assays identified two potent activators. Structural analyses via NMR spectroscopy, mass spectrometry and computational modeling confirmed structural perturbations of the carbohydrate recognition domain (CRD) and revealed distinct mechanisms of activation. While both activators significantly enhanced DC‐SIGN's affinity for monosaccharide ligands, one compound induced oligomerization via covalent coupling and non‐covalent secondary site interactions, whereas the other selectively modified lysine K373 directly within the primary carbohydrate binding site. These findings demonstrate the potential of lysine‐targeted covalent compounds as a novel therapeutic strategy for modulating DC‐SIGN function and potentially C‐type lectins in general.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lectins, C-TypeCell Adhesion MoleculesReceptors, Cell SurfaceHumansBinding SitesLysineLigands

Stichwörter der Autor:innen

Covalent inhibitionDC‐SIGNFragment‐based drug designGlycobiologyProtein activation

Substanzen

Lectins, C-TypeCell Adhesion MoleculesReceptors, Cell SurfaceLysineLigands

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, Vienna, 1090, Austria.
  • Department of Microbiology, Immunology and Genetics, Max F. Perutz Labs, Biocenter 5, Vienna, 1030, Austria.
  • Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna, Vienna, Austria.
  • Medicinal Chemistry Research Group, HUN-REN Research Centre for Natural Sciences, Magyar tudósok krt 2, Budapest, H-1117, Hungary.
  • Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3., Budapest, H-1111, Hungary.
  • National Laboratory for Drug Research and Development, HUN-REN Research Centre for Natural Sciences, Magyar tudósok krt 2, Budapest, H-1117, Hungary.

ORCID-Profile: Jonathan Lefèbre, Maurice Besch, Noémi Csorba, Kristóf Garami, Zoltán Orgován, Gitta Schlosser, Iris Bermejo, Péter Ábrányi-Balogh, György M Keserű, Christoph Rademacher

Förderung

  • European Commission for a Marie-Skłodowska Curie Fellowship
  • Doctoral Excellence Fellowship Programme
  • Marie Skłodowska Curie
  • National Research Fund, Luxembourg, AFR
  • National Laboratory for Drug Research and Development (PharmaLab)

Zitieren

APA

Lefèbre, J., Besch, M., Csorba, N., Garami, K., Orgován, Z., Schlosser, G., Bermejo, I., Ábrányi-Balogh, P., Keserű, G. M., & Rademacher, C. (2026). Covalent Activation of the C‐type Lectin DC‐SIGN. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202520594

Vancouver

Lefèbre J, Besch M, Csorba N, Garami K, Orgován Z, Schlosser G, et al. Covalent Activation of the C‐type Lectin DC‐SIGN. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.202520594

BibTeX
@article{Lefbre2026,
  author = {Lefèbre, Jonathan and Besch, Maurice and Csorba, Noémi and Garami, Kristóf and Orgován, Zoltán and Schlosser, Gitta and Bermejo, Iris and Ábrányi-Balogh, Péter and Keserű, György M and Rademacher, Christoph},
  title = {Covalent Activation of the C‐type Lectin DC‐SIGN},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  doi = {10.1002/anie.202520594}
}
Kostenlos starten →